← Evidence map

ArticleScientific reports2021

The inhibition of ABCB1/MDR1 or ABCG2/BCRP enables doxorubicin to eliminate liver cancer stem cells.

Wang Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

44 papers cite it

2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 34031441